Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.22% | 196.96 | 1.2% | $506.18m | |
| GILD | Gilead Sciences, Inc. | -0.54% | 73.19 | 0.9% | $444.63m | |
| BIIB | Biogen Inc. | -0.53% | 329.18 | 1.3% | $366.64m | |
| CELG | Celgene Corporation | -0.29% | 82.34 | 1.2% | $329.49m | |
| ILMN | Illumina, Inc. | -1.79% | 315.93 | 3.5% | $285.25m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.82% | 377.16 | 2.6% | $219.86m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.17% | 122.15 | 2.0% | $209.10m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.22% | 179.10 | 1.9% | $200.99m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.02% | 131.84 | 16.4% | $168.13m | |
| A | Agilent Technologies, Inc. | -0.33% | 66.02 | 1.5% | $154.03m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.80% | 100.31 | 4.4% | $129.38m | |
| LGND | Ligand Pharmaceuticals Incorporated | -1.02% | 200.52 | 23.3% | $107.04m | |
| VKTX | Viking Therapeutics, Inc. | -2.14% | 14.15 | 0.9% | $106.43m | |
| NKTR | Nektar Therapeutics | 0.37% | 49.09 | 5.6% | $105.85m | |
| EXAS | Exact Sciences Corporation | -1.77% | 66.03 | 25.3% | $96.40m |
Company Profile
Xenetic Biosciences, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, research, and development of next generation biologic drugs and novel orphan oncology therapeutics. Its lead investigational product candidate is oncology therapeutic XBIO-101 (sodium cridanimod), which focuses on the treatment of progesterone resistant endometrial cancer. It also offers proprietary drug development platform, PolyXen, which enables next-generation biologic drugs by improving their half-life and other pharmacological properties. The company was founded on August 9, 2011 and is headquartered in Lexington, MA.